Brokerages Set Astrana Health, Inc. (NASDAQ:ASTH) Price Target at $65.17

Astrana Health, Inc. (NASDAQ:ASTH) has earned an average recommendation of “Moderate Buy” from the nine analysts that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $65.17.

ASTH has been the topic of several recent analyst reports. TD Cowen assumed coverage on Astrana Health in a report on Monday, October 14th. They set a “buy” rating and a $66.00 target price on the stock. Robert W. Baird lifted their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. KeyCorp began coverage on Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. BTIG Research raised their price target on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. Finally, Macquarie raised shares of Astrana Health to a “hold” rating in a research note on Monday, December 16th.

Hedge Funds Weigh In On Astrana Health

Institutional investors have recently modified their holdings of the stock. Janus Henderson Group PLC acquired a new position in Astrana Health during the 3rd quarter worth $1,164,000. Royce & Associates LP bought a new position in Astrana Health in the third quarter valued at about $6,661,000. Amalgamated Bank acquired a new stake in Astrana Health in the third quarter worth about $713,000. Principal Financial Group Inc. bought a new stake in Astrana Health during the 3rd quarter worth about $13,383,000. Finally, Diamond Hill Capital Management Inc. acquired a new position in Astrana Health during the 3rd quarter valued at about $8,245,000. 52.77% of the stock is owned by institutional investors.

Astrana Health Stock Down 0.7 %

Shares of Astrana Health stock opened at $33.47 on Tuesday. The stock has a market cap of $1.88 billion, a price-to-earnings ratio of 25.75, a price-to-earnings-growth ratio of 1.80 and a beta of 1.14. Astrana Health has a twelve month low of $33.18 and a twelve month high of $63.20. The company has a fifty day moving average price of $46.70 and a 200 day moving average price of $47.86. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last issued its earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting the consensus estimate of $0.33. The company had revenue of $478.71 million during the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same quarter last year, the firm earned $0.47 EPS. Equities research analysts forecast that Astrana Health will post 1.16 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.